4//SEC Filing
GIBSON NEIL 4
Accession 0001209191-04-044396
CIK 0000729922other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 3:41 PM ET
Size
15.5 KB
Accession
0001209191-04-044396
Insider Transaction Report
Form 4
GIBSON NEIL
VP & Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2004-09-13$30.74/sh+2,000$61,480→ 3,590 total - Sale
Common Stock
2004-09-13$63.03/sh−200$12,606→ 1,915 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-09-13−2,000→ 17,200 totalExercise: $30.74From: 2004-06-25Exp: 2013-06-24→ Common Stock (2,000 underlying) - Sale
Common Stock
2004-09-13$63.00/sh−1,175$74,025→ 2,415 total - Sale
Common Stock
2004-09-13$63.02/sh−300$18,906→ 2,115 total - Sale
Common Stock
2004-09-13$63.07/sh−125$7,884→ 1,590 total
Footnotes (3)
- [F1]One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months.
- [F2]The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3.
- [F3]Includes only options with the same termination date.
Documents
Issuer
OSI PHARMACEUTICALS INC
CIK 0000729922
Entity typeother
Related Parties
1- filerCIK 0001220036
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 3:41 PM ET
- Size
- 15.5 KB